Twitter post by Biovaxys"Post acquisition , we are very pleased to hear in multiple meetings that principal investigators involved in the prior DPX clinical studies are excited and intriquesd w/the emerging data and prospects for DPX, and have asked to restart / continue these climical studies with BIOVAXYS".
GL